The decision is part of the Takeda’s goal to divest $10 billion in non-core assets and focus on its key business areas. Takeda announced on April 24, 2020 that it has entered into an agreement to ...
TOKYO, April 24 (Reuters) - Takeda Pharmaceutical Co said it would sell selected over-the-counter (OTC) and prescription pharmaceutical products that are sold in Europe to Orifarm Group. The sale, ...
OSAKA, Japan--(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its previously-announced sale of a portfolio of select products ...
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ("Takeda") today announced the completion of its previously-announced sale of a portfolio of select products to Orifarm Group ("Orifarm") for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results